| Latvia |
Central office of JSC «Grindeks» is located in the capital of Latvia – Riga, ensuring the monitoring, governance and management of the Group. Manufacturing units of «Grindeks» active pharmaceutical ingredients, final dosage forms, capsules and syrups are located in Riga.
Read more 
|
| Lithuania |
Representative office of JSC «Grindeks» in Lithuania was opened in 1997; affiliate of «Grindeks» was developed in 2005.
Read more 
|
| Estonia |
«Grindeks» subsidiary company "Tallinn pharmaceutical plant", where ointments are produced, is located in Estonia.
Read more
|
| Belarus |
Representative office of JSC «Grindeks» operates in Belarus since January 2002. The main duty of the office is sales and distribution of the products in the local market, securing stable cooperation with the main wholesalers and performing activities for the awareness rising of «Grindeks» brand, as well as ensuring the registration process of «Grindeks» medications in Belarus.
Read more
|
| Russia |
Russia is one of the biggest realization markets of «Grindeks», one third of the final dosage medications of «Grindeks» were exported to Russia in 2005. Since 2001, «Grindeks» is also exporting active pharmaceutical ingredients (Oxytocine and Droperidol) to Russia.
Read more
|
| Ukraine |
Representative office of JSC «Grindeks» operates in Ukraine since August 2005. The main task of it is to ensure registration process of «Grindeks» products in Ukraine, sales and distribution of medications in the local market, while securing stable cooperation with the main wholesalers and performing activities for the awareness rising of «Grindeks» brand.
Read more
|
| Moldova |
Representative office of JSC «Grindeks» operates in Moldova since February 2006. The main task of it is to ensure registration process of «Grindeks» products in Moldova, sales and distribution of medications in the local market, while securing stable cooperation with the main wholesalers and performing activities for the awareness rising of «Grindeks» brand.
Read more
|
| Poland |
JSC «Grindeks» has entered into agreement of registration and cooperation with the Polish company "ELJOT" that is authorised to represent interests of «Grindeks» in Poland. "ELJOT" deals with the registration of «Grindeks» products, marketing and sales, as well as solves different issues and uncertainties. Products that are exported to Poland are ointment Viprosal® and injections of Oxytocine.
Read more
|
| Czech Republic |
«Grindeks» has entered into an agreement of registration and cooperation with the company of Czech Republic "K+K Pharma" that is authorised to represent interests of «Grindeks» in Czech Republic. "K+K Pharma" deals with the registration, sales and marketing of «Grindeks» products. «Grindeks» in Czech Republic is selling capsules of the brand product Ftorafur®.
Read more
|
| Hungary |
«Grindeks» has entered into registration and cooperation agreement with the Hungarian company "Medi-Zone Kft", that is authorised to represent interests of «Grindeks» in Hungary. "Medi-Zone Kft" deals with the registration, sales and marketing of «Grindeks» products. «Grindeks» in Hungary is selling capsules of the brand product Ftorafur®.
Read more
|
| Finland |
In 2004, JSC «Grindeks» entered into the sales agreement with the Finnish chain of pharmacies "Scanpharma", as well as started the registration of certain products in Finland – Zopiclone, Paraceptamol, Aspirin, Ibuprofen, Loperamid. Active pharmaceutical ingredient Zopiclone is exported to Finland.
Read more
|
| Germany |
JSC «Grindeks» has stable and continuous cooperation with the company "Merck Group"; its headquarters are located in Germany.
Read more
|
| Austria |
JSC «Grindeks» exports and sells active pharmaceutical ingredient Oxytocine to Austria.
Read more
|
| Switzerland |
Cooperation of JSC «Grindeks» with Switzerland started in 2001. «Grindeks» is exporting active pharmaceutical ingredients Oxytocine and Droperidol to Switzerland.
Read more
|
| Bulgaria |
JSC «Grindeks» has entered into the agreement of registration and cooperation with the Bulgarian company "Sopharm" on the registration and distribution of «Grindeks» products Mildronate® (capsules in injections), Ftorafur®, Venlafaksin, Somnol® and Riperoidon.
Since 2001 active pharmaceutical ingredient Oxytocine is exported to and sold in Bulgaria.
Read more
|
| Belgium |
In 2006, JSC «Grindeks» started cooperation with the Belgium company "Pagan". «Grindeks» is exporting active pharmaceutical ingredient Droperidol to Belgium.
Read more
|
| Denmark |
Since 2001, JSC «Grindeks» started active participation in Danish market. «Grindeks» is exporting active pharmaceutical ingredient Oxytocine to Denmark. «Grindeks» started cooperation with the Danish company "Polypeptide Laboratories" for the purpose of selling active pharmaceutical ingredients in 2004.
Read more
|
| Netherland |
Since 2001, JSC «Grindeks» started cooperation with the Netherlands. The company is exporting active pharmaceutical ingredients Oxytocine, Droperidol, Citarabin to the Netherlands. In 2005, «Grindeks» started cooperation with the Dutch company "Eurovet Animal health" on the development of new products (substances) to the veterinary market.
Read more
|
| France |
JSC «Grindeks» started cooperation with France in 2001. The company is exporting active pharmaceutical ingredients – Oxytocine, Droperidol and Rilmenidine to France. Along with the sales of active pharmaceutical ingredients, «Grindeks» has developed successful cooperation with the company "Merck Generiques" (part of the "Merck Group") in terms of the research, development and sales of substances to the French market.
Read more |
| Spain |
Since 2001, JSC «Grindeks» is exporting and selling active pharmaceutical ingredient Oxytocine to the Spanish market.
Read more
|
| Great Britan |
JSC «Grindeks» started to export substances to Great Britain in 2001; export volume is increasing yearly.
Read more
|
| Ireland |
JSC «Grindeks» started cooperation with Ireland in 2001 by exporting active pharmaceutical ingredient Zopiclone.
Read more
|
| Italy |
JSC «Grindeks» is exporting and selling active pharmaceutical ingredient Oxytocine to the Iltalian market.
Read more |
| Sweden |
Cooperation of «Grindeks» with Sweden started in 2009. This cooperation began with the delivery of an active pharmaceutical ingredient Oxytocin.
Read more
|
